Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

NHLBI Structural Heart and Valve Network Prospective Registry

NCT03928639 is registered in ClinicalTrials.gov with National Heart, Lung, and Blood Institute (NHLBI) as lead sponsor.

NCT NCT03928639
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03928639 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
NHLBI Structural Heart and Valve Network Prospective Registry
Lead sponsor
National Heart, Lung, and Blood Institute (NHLBI)
Phase
Observational
Overall status
Withdrawn
Start date
January 10, 2023
Completion date
January 10, 2023
Enrollment
0 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

aortic valve stenosis, heart failure, heart valve disease, mitral valve regurgitation, tricuspid valve regurgitation